| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.912 | 0 | 0.912 | 5-Alpha-reductase 2 inhibitor | 0.71 0.001 CID_20034539 | ||
| 0.909 | 0 | 0.909 | 5-Alpha-reductase 1 inhibitor | 0.714 0.001 CID_20034539 | ||
| 0.898 | 0.001 | 0.898 | 5-Alpha-reductase inhibitor | 0.876 0.001 CID_20034539 | ||
| 0.869 | 0.002 | 0.901 | Androgen antagonist | 0.901 0.002 CID_20034539 | CID_20034539 | |
| 0.475 | 0.002 | 0.488 | Androgen agonist | 0.488 0.002 CID_20034539 | CID_20034539 | |
| 0.436 | 0.009 | 0.436 | Sodium/bile acid cotransporter inhibitor | 0.43 0.01 CID_20034539 | ||
| 0.334 | 0.015 | 0.334 | Lipocortins synthesis antagonist | 0.319 0.018 CID_20034539 | ||
| 0.421 | 0.127 | 0.444 | Antiinflammatory | 0.444 0.113 CID_20034539 | CID_20034539 | |
| 0.288 | 0.016 | 0.288 | Antipruritic | 0.225 0.034 CID_20034539 | ||
| 0.272 | 0.022 | 0.272 | NOS3 expression enhancer | 0.181 0.05 CID_20034539 | ||
| 0.288 | 0.046 | 0.288 | Psychostimulant | 0.167 0.102 CID_20034539 | ||
| 0.302 | 0.072 | 0.32 | Interleukin 2 agonist | 0.32 0.061 CID_20034539 | CID_20034539 | |
| 0.327 | 0.099 | 0.488 | Immunosuppressant | 0.488 0.036 CID_20034539 | CID_20034539 | |
| 0.246 | 0.031 | 0.345 | Diuretic | 0.345 0.017 CID_20034539 | CID_20034539 | |
| 0.183 | 0.017 | 0.183 | Pregnane X receptor agonist | 0.144 0.064 CID_20034539 | ||
| 0.188 | 0.023 | 0.188 | Microtubule formation inhibitor | 0.155 0.035 CID_20034539 | ||
| 0.243 | 0.084 | 0.353 | Interleukin agonist | 0.353 0.028 CID_20034539 | CID_20034539 | |
| 0.158 | 0.005 | 0.158 | Aldosterone antagonist | 0.11 0.008 CID_20034539 | ||
| 0.156 | 0.015 | 0.156 | Anabolic | 0.134 0.028 CID_20034539 | ||
| 0.162 | 0.024 | 0.162 | Antineoplastic alkaloid | 0.142 0.03 CID_20034539 | ||
| 0.185 | 0.048 | 0.199 | Arachidonic acid antagonist | 0.199 0.034 CID_20034539 | CID_20034539 | |
| 0.161 | 0.04 | 0.161 | Proteasome inhibitor | 0.106 0.08 CID_20034539 | ||
| 0.16 | 0.042 | 0.16 | Farnesoid X receptor antagonist | 0.16 0.042 CID_20034539 | ||
| 0.236 | 0.123 | 0.236 | Ca(v)3.3 blocker | |||
| 0.107 | 0.004 | 0.107 | Lipocortins synthesis agonist | 0.103 0.005 CID_20034539 | ||
| 0.107 | 0.008 | 0.107 | Gonadotropin-releasing hormone receptor agonist | 0.101 0.01 CID_20034539 | ||
| 0.232 | 0.138 | 0.34 | Cholesterol antagonist | 0.34 0.069 CID_20034539 | CID_20034539 | |
| 0.159 | 0.067 | 0.16 | Interferon gamma antagonist | 0.16 0.066 CID_20034539 | CID_20034539 | |
| 0.096 | 0.008 | 0.096 | Mineralocorticoid receptor antagonist | 0.078 0.012 CID_20034539 | ||
| 0.083 | 0.007 | 0.083 | Chemokine receptor agonist | 0.056 0.03 CID_20034539 | ||
| 0.104 | 0.029 | 0.104 | Glycine receptor antagonist | |||
| 0.082 | 0.008 | 0.082 | RNA-directed RNA polymerase stimulant | 0.066 0.01 CID_20034539 | ||
| 0.072 | 0.002 | 0.072 | Corticosteroid-like | 0.06 0.003 CID_20034539 | ||
| 0.076 | 0.007 | 0.076 | Glucocorticoid antagonist | 0.063 0.01 CID_20034539 | ||
| 0.109 | 0.047 | 0.109 | Prolactin inhibitor | 0.084 0.075 CID_20034539 | ||
| 0.067 | 0.005 | 0.067 | Glucose-6-phosphate dehydrogenase inhibitor | 0.062 0.006 CID_20034539 | ||
| 0.099 | 0.04 | 0.099 | Acetylcholine nicotinic antagonist | |||
| 0.059 | 0.001 | 0.059 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.046 0.001 CID_20034539 | ||
| 0.078 | 0.02 | 0.078 | Bombesin 3 receptor antagonist | |||
| 0.203 | 0.146 | 0.203 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.149 | 0.095 | 0.149 | Nitric oxide antagonist | 0.146 0.099 CID_20034539 | ||
| 0.098 | 0.046 | 0.098 | Acetylcholine M3 receptor agonist | 0.076 0.064 CID_20034539 | ||
| 0.12 | 0.07 | 0.12 | Acetylcholine antagonist | |||
| 0.122 | 0.072 | 0.122 | Cholinergic antagonist | |||
| 0.256 | 0.208 | 0.256 | Apoptosis agonist | 0.24 0.225 CID_20034539 | ||
| 0.063 | 0.015 | 0.063 | Nicotinic acid receptor 1 agonist | 0.05 0.02 CID_20034539 | ||
| 0.08 | 0.034 | 0.08 | Phospholipase D inhibitor | 0.069 0.055 CID_20034539 | ||
| 0.048 | 0.005 | 0.048 | CXC chemokine receptor agonist | 0.036 0.023 CID_20034539 | ||
| 0.056 | 0.013 | 0.056 | Nicotinic receptor beta4 subunit antagonist | 0.033 0.032 CID_20034539 | ||
| 0.21 | 0.167 | 0.21 | Apoptosis antagonist | |||
| 0.08 | 0.038 | 0.086 | Glycine receptor agonist | 0.086 0.032 CID_20034539 | CID_20034539 | |
| 0.057 | 0.015 | 0.057 | Progesterone antagonist | 0.031 0.028 CID_20034539 | ||
| 0.088 | 0.048 | 0.088 | Opioid kappa receptor antagonist | |||
| 0.15 | 0.11 | 0.188 | Hepatoprotectant | 0.188 0.073 CID_20034539 | CID_20034539 | |
| 0.042 | 0.005 | 0.042 | Glucocorticoid agonist | 0.03 0.006 CID_20034539 | ||
| 0.066 | 0.031 | 0.066 | Heme oxygenase stimulant | 0.062 0.04 CID_20034539 | ||
| 0.052 | 0.018 | 0.052 | Parathyroid hormone antagonist | 0.05 0.022 CID_20034539 | ||
| 0.042 | 0.009 | 0.042 | Estrone sulfatase inhibitor | 0.024 0.013 CID_20034539 | ||
| 0.181 | 0.152 | 0.236 | DNA synthesis inhibitor | 0.236 0.077 CID_20034539 | CID_20034539 | |
| 0.05 | 0.024 | 0.05 | Opioid kappa receptor agonist | |||
| 0.145 | 0.119 | 0.171 | Anesthetic general | 0.171 0.093 CID_20034539 | CID_20034539 | |
| 0.096 | 0.072 | 0.096 | Hedgehog signaling inhibitor | |||
| 0.032 | 0.009 | 0.032 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.027 | 0.008 | 0.027 | Progesterone agonist | 0.02 0.011 CID_20034539 | ||
| 0.102 | 0.084 | 0.114 | DNA polymerase I inhibitor | 0.114 0.073 CID_20034539 | CID_20034539 | |
| 0.033 | 0.015 | 0.033 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.028 | 0.017 | 0.028 | Hedgehog signaling activator | |||
| 0.046 | 0.039 | 0.046 | HCV NS3/NS4A protease inhibitor | |||
| 0.022 | 0.015 | 0.022 | Vitamin D receptor antagonist | 0.022 0.015 CID_20034539 | ||
| 0.164 | 0.16 | 0.299 | Peptidyltransferase inhibitor | 0.299 0.025 CID_20034539 | CID_20034539 | |
| 0.181 | 0.178 | 0.181 | Gastrin inhibitor | |||
| 0.054 | 0.053 | 0.054 | Ca(v)3.2 blocker | |||
| 0.018 | 0.017 | 0.018 | Progesterone receptor B antagonist | |||
| 0.063 | 0.067 | 0.067 | Na+ K+ transporting ATPase inhibitor | 0.067 0.063 CID_20034539 | CID_20034539 | |
| 0.116 | 0.128 | 0.125 | Growth hormone agonist | 0.125 0.113 CID_20034539 | CID_20034539 | |
| 0.129 | 0.176 | 0.185 | Immunostimulant | 0.185 0.129 CID_20034539 | CID_20034539 | |
| 0.107 | 0.228 | 0.144 | Phospholipase C inhibitor | 0.144 0.119 CID_20034539 | CID_20034539 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |